Covaxin phase 4 trials to be conducted soon, phase 3 data to be out in July: Bharat Biotech
Bharat Biotech is going to conduct a phase 4 trial of its COVID-19 vaccine, Covaxin, in order to check the real-world effectiveness. The company revealed that the results for the phase 3 trial will be published next month.
Jun 10, 2021, 07:36 AM IST
'Not scientifically designed': Bharat Biotech rejects study that claimed Covaxin less effective than Covishield
The Hyderabad-based COVID vaccine manufacturer also said that it will publish the phase 3 trial data in July and after that, it will be applying for the full licensure of COVAXIN.
Jun 09, 2021, 19:16 PM IST
